Erythromycin--three decades later.

Area of Science:

• Clinical microbiology
• Pharmacology
• Immunology

Background:

• Erythromycin is a widely used antibiotic with established efficacy.
• Recent developments highlight its expanding clinical applications.
• Understanding its interactions and effects on the host immune system is crucial.

Purpose of the Study:

• To review recent clinical developments concerning erythromycin.
• To discuss its spectrum of activity, particularly in respiratory infections.
• To explore its use in treating sexually transmitted diseases, Legionella, and enteritides.

Main Methods:

• Literature review of recent studies on erythromycin's clinical usage.
• Analysis of its bactericidal and tissue-penetrating properties.
• Examination of its immunomodulatory effects and drug interactions.

Main Results:

• Erythromycin demonstrates a useful spectrum for respiratory tract infections.
• Its application is increasing for sexually acquired disorders, Legionella, Campylobacter, and Shigella infections.
• Interactions with theophylline, carbamazepine, and plasma alpha-1-glycoprotein are significant.

Conclusions:

• Erythromycin remains a valuable and safe antibiotic with diverse clinical applications.
• Its immunomodulatory effects and drug interactions require further investigation.
• Clinicians should remain aware of its continued relevance and expanding utility.